Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Asia
Japanese pharmaceutical company Astellas and German biopharmaceutical company Ganymed have entered into an agreement under which Astellas will acquire Ganymed for €422 million.   31 October 2016
Americas
Kyle Bass’s organisation the Coalition for Affordable Drugs has won a patent battle against NPS Pharmaceuticals at the Patent Trial and Appeal Board after successfully proving claims covering Gattex to be unpatentable.   31 October 2016
Americas
Customs is a useful tool that can be used to fight counterfeiters, according to Bruce Longbottom, assistant general counsel, trademarks at Eli Lilly.   31 October 2016
Americas
Allergan will acquire biopharmaceutical company Motus Therapeutics, a wholly-owned subsidiary of Rhythm Holding Company, for $200 million.   28 October 2016
Americas
The regents of the University of California, the institution’s governing body, has filed a complaint against medical device company St. Jude Medical for allegedly infringing patents covering a method of treating atrial fibrillation.   28 October 2016
Big Pharma
The University of Sussex, based in the UK, is planning a new life sciences building that will create approximately 600 new jobs across Brighton, Hove and the neighbouring region.   27 October 2016
Americas
Varian Medical Systems, a radiation oncology treatments and software maker, has filed a lawsuit seeking a declaratory judgment of non-infringement in a patent dispute with Swedish cancer treatment company Elekta.   27 October 2016
Americas
Japanese company Sumitomo Dainippon Pharma’s US subsidiary, Sunovion Pharmaceuticals, has completed the acquisition of Cynapsus Therapeutics.   26 October 2016
Americas
Japan-based Otsuka Pharmaceuticals has filed a complaint against US-based Zydus Pharmaceuticals for allegedly infringing a patent directed to the drug Abilify.   26 October 2016
Americas
Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan.   25 October 2016